Patient Marketing Group in deal with Discovery.com

Share this article:
Relationship marketing firm Patient Marketing Group (PMG)
has joined forces with the consumer Web site Discovery.com as a provider of the Internet portal's health-related content.
As part of the deal announced this week, content from PMG's online medical encyclopedia will be made available on the Discovery Health section of Discovery.com as well as DiscoveryHospital.com, a consumer health Internet content service
designed for hospitals.
"This multi-year agreement will create a large-scale new media resource for our clients to more precisely target health promotions to prospects who are actively searching for such information," said Lynn Benzing, PMG president.
Consumers will be able to link to PMG from Discovery.com, bringing them "into our environment, where we can learn more about them," Benzing said.
"Several aspects of content delivery are still under development," Benzing added.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...